1-14 of 14
Jeremy Abramson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Free
Paolo Lopedote, Adrienne Nedved, Lu Chen, Marcus Watkins, Arian Roua, Muhamad Alhaj Moustafa, Seyi Abidoye, Yun Choi, Georgios Pongas, Tony Zhuang, Jean Clement, Megan Searssmith, Laura Sun, Hannah Willis, Brad Kahl, David Bond, Javier Munoz, Izidore S. Lossos, Craig Portell, Michael Wang, Nilanjan Ghosh, Jonathon Cohen, Peter Martin, Jeremy Abramson, Anne Beaven, Patrick Reagan, Daniel Ermann, Taylor Brooks, Ashlee Joseph, Nazila Shafagati, Daniel McLoughlin, Kira Rosenlind, Brian Hill, Nina Wagner-Johnston, Anita Kumar, Umar Farooq, Reem Karmali, Tanaya Shree, Matthew Lunning, Stacy Pak, Alexey Danilov, Yucai Wang, Tycel Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 5351.
https://doi.org/10.1182/blood-2025-5351
Published: 2025
Journal Articles

Preliminary safety and efficacy of boven (Zanubrutinib, Obinutuzumab, and Venetoclax) as frontline therapy for older patients with Mantle Cell Lymphoma

Free
Anita Kumar, Jacob Soumerai, Reem Karmali, Jeremy Abramson, Jeffrey Barnes, Bernadette Beatty, Jason Brecher, Philip Caron, Kenneth Carson, Maria Chabowska, Madelyn Coogan, Jayne Coyle, Kevin David, Meemanage De Zoysa, Ahmet Dogan, Zachary Epstein-Peterson, Paola Ghione, Cameron Gordan, Leo Gordon, Julie Haydu, Ephraim Hochberg, Patrick Connor Johnson, Ashlee Joseph, Akshata Kakolu, Alyssa Labarre, Carissa Laudati, Jennifer Lue, Shuo Ma, Rosalba Martignetti, Colette Owens, Olivia Maas, Joanna Mi, Rachel Nazzaro, James O'Grady, Jessica Pendleton, Gilles Salles, Venkatraman Seshan, Natalie Slupe, Pallawi Torka, Andrew Zelenetz
Journal: Blood
Blood (2025) 146 (Supplement 1): 888.
https://doi.org/10.1182/blood-2025-888
Published: 2025
Journal Articles

INSIGHT: A baseline laboratory profile independently predicts outcomes and demonstrates superiority of lisocabtagene maraleucel (liso-cel) over standard of care (SOC) in second-line (2L) large B-cell lymphoma (LBCL) regardless of baseline profile

Free
Sahar Ansari, Manali Kamdar, Eniko Papp, Mazyar Shadman, Jeremy Abramson, Begüm D. Topçuoglu, Pei Yang, Lara Stepan, Pradipta Ray, Amanda Przespolewski, Krishna R. Juluri, Eric Bleickardt, Debasmita Roy, Alessandro Crotta, Timothy B. Campbell, Julie A. Rytlewski, Abood Okal, Ethan Thompson, Leanne Peiser
Journal: Blood
Blood (2025) 146 (Supplement 1): 1775.
https://doi.org/10.1182/blood-2025-1775
Published: 2025
Journal Articles

Sustained clinical benefit of glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab plus GemOx (R-GemOx) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 3-year follow-up of STARGLO

Free
Jeremy Abramson, Matthew Ku, Christopher Fox, Huiqiang Huang, Huilai Zhang, William Townsend, Dok Hyun Yoon, Won-Seog Kim, Haifaa Abdulhaq, Charles Herbaux, Jan Zaucha, Hung Chang, Estefania Mulvihill, Murali Kesavan, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Alessia Bottos, Linda Lundberg, Gareth P. Gregory
Journal: Blood
Blood (2025) 146 (Supplement 1): 5519.
https://doi.org/10.1182/blood-2025-5519
Published: 2025
Journal Articles

Glofitamab plus gemcitabine and oxaliplatin (GemOx) vs rituximab (R)-GemOx in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Efficacy and safety in patient subgroups

Free
Haifaa Abdulhaq, William Townsend, Matthew Ku, Gareth P. Gregory, Jeremy Abramson, Huiqiang Huang, Huilai Zhang, Dok Hyun Yoon, Won-Seog Kim, Herve Ghesquieres, Mark Hertzberg, Qing-Yuan Zhang, Murali Kesavan, Estefania Mulvihill, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Linda Lundberg, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 3743.
https://doi.org/10.1182/blood-2025-3743
Published: 2025
Journal Articles

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma

Free
Leon D. Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, Jeremy Abramson, Jacob Soumerai, Maria Martinez-Lage, Julie Haydu, Ganesh Shankar, Chirayu Patel, Bryan D. Choi, Jeffrey Barnes, Areej El-Jawahri, Ephraim Hochberg, Patrick Connor Johnson, Wolfgang Wick, Marcela Maus, Yi-Bin Chen, Matthew Frigault, Jorg Dietrich
Journal: Blood
Blood (2025) 146 (Supplement 1): 5493.
https://doi.org/10.1182/blood-2025-5493
Published: 2025
Journal Articles

Performance of different large language models (LLMs) as decision support tools across various hematologic malignancies

Free
Chadi Nabhan, Jeremy Abramson, Tyler Fraum, Ajay Nooka, Gary Schiller, David Schuster, Michael Thirman, Kayla Haines, Erin Shonkwiler, Mohammad Jahanzeb
Journal: Blood
Blood (2025) 146 (Supplement 1): 4359.
https://doi.org/10.1182/blood-2025-4359
Published: 2025
Journal Articles

Trial in progress: Open-label dose-finding and dose-expansion study to evaluate the safety, expansion, persistence, and clinical activity of UCART20x22 in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) nathali-01

Free
Jeremy Abramson, Aravind Ramakrishnan, Emmanuel Bachy, Laurent Poirot, Xenia Naj, Vivian Dai, Sophie Ramadier, Adrian Kilcoyne
Journal: Blood
Blood (2025) 146 (Supplement 1): 3731.
https://doi.org/10.1182/blood-2025-3731
Published: 2025
Journal Articles

First-line consolidation with cemacabtagene ansegedleucel (cema-cel) in patients with large B-cell lymphoma (LBCL) and minimal residual disease (MRD) after response to standard therapy: The pivotal, randomized, open‑label Phase 2 ALPHA3 study

Free
John M. Burke, Nancy Bartlett, Gary L. Simmons, Lindsey Fitzgerald, Jeremy Abramson, Akil Merchant, Paolo Caimi, Rushang D. Patel, Don Stevens, Sven de Vos, Oleg L. Krijanovski, Geoffrey Shouse, Alex Herrera, Houston Holmes, Matthew Matasar, Mitul Gandhi, Frederick Locke, John Kuruvilla, Amy Feng, Joe Jiang, Shilpa Shahani, John B. Le Gall, Zachary J. Roberts, Jason Westin
Journal: Blood
Blood (2025) 146 (Supplement 1): 3730.
https://doi.org/10.1182/blood-2025-3730
Published: 2025
Journal Articles

Lisocabtagene maraleucel (liso-cel) versus standard of care (SOC) for second-line relapsed or refractory large B-cell lymphoma (LBCL): First Results from long-term follow-up of TRANSFORM

Free
Manali Kamdar, Scott Solomon, Jon Arnason, Patrick Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew Lunning, Vincent Ribrag, Yi Lin, Rashmi Bhatnagar, Sandrine Montheard, Jeremy Abramson
Journal: Blood
Blood (2025) 146 (Supplement 1): 3710.
https://doi.org/10.1182/blood-2025-3710
Published: 2025
Journal Articles

Patient-reported outcomes (PROs) with lisocabtagene maraleucel (liso-cel) in patients with third line or later (3L+) R/R MZL from the Phase 2 TRANSCEND FL study

Free
Reem Karmali, Franck Morschhauser, Koji Izutsu, Lia Palomba, Kirit Ardeshna, Brian Hill, Manali Kamdar, Stephen J. Schuster, Antonio Pinto, Saurabh Dahiya, Merav Bar, Maria Strocchia, Jinender Kumar, Jeremy Abramson
Journal: Blood
Blood (2025) 146 (Supplement 1): 709.
https://doi.org/10.1182/blood-2025-709
Published: 2025
Journal Articles

Three-Year Efficacy and Longitudinal Safety of Lisocabtagene Maraleucel (liso-cel) in Patients With Third-Line or Later (3L+) Follicular Lymphoma (FL) From TRANSCEND FL

Free
Sairah Ahmed, Alejandro Martin Garcia-Sancho, Juan Luis Reguera, Guillaume Cartron, Aaron P. Rapoport, Koji Izutsu, Herve Ghesquieres, Hideki Goto, Jeremy Abramson, Peter Borchmann, Ulrich Jaeger, Manali Kamdar, Martin Dreyling, Merav Bar, Maria Strocchia, Martina Raggi, Luciana Bueno, Jessica Papuga, Silvia Colicino, Franck Morschhauser
Journal: Blood
Blood (2025) 146 (Supplement 1): 467.
https://doi.org/10.1182/blood-2025-467
Published: 2025
Journal Articles

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Free
Clinical Trials & Observations Brief Report
Matthew J. Frigault, Jorg Dietrich, Maria Martinez-Lage, Mark Leick, Bryan D. Choi, Zachariah DeFilipp, Yi-Bin Chen, Jeremy Abramson, Jennifer Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus
Journal: Blood
Blood (2019) 134 (11): 860–866.
https://doi.org/10.1182/blood.2019001694
Published: 2019
Includes: Supplemental data
Journal Articles

Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303

Free
Wyndham H. Wilson, MD PhD, Jung sin-Ho, Brandelyn Nicole Pitcher, MS, Eric D Hsi, MD, Jonathan Friedberg, MD, Bruce Cheson, MD, Nancy L Bartlett, MD, Scott Smith, Nina Wagner Johnston, MD, Brad S Kahl, Louis M. Staudt, MD PhD, Kristie Blum, MD, Jeremy Abramson, Oliver W Press, MD PhD, Richard I. Fisher, MD, Kristy L. Richards, PhD MD, Heiko Schoder, MD, Julie E Chang, Andrew D. Zelenetz, John P. Leonard, MD
Journal: Blood
Blood (2016) 128 (22): 469.
https://doi.org/10.1182/blood.V128.22.469.469
Published: 2016